Paul Berg Regulating biotechnological discoveries hasn't gotten any easier since scientists and policymakers faced their first major challenge 25 years ago. In 1973, recombinant DNA technology burst onto the scene.1 The response was remarkably swift. A group of scientists led by Paul Berg, now director of the Beckman Center for Molecular and Genetic Research at the Stanford University School of Medicine, called for an international moratorium on recombinant DNA research, fearing that the technol
 Paul Berg |
In February 1975, an elite group of scientists, policymakers, and journalists assembled for the now-famous Asilomar meeting in Pacific Grove, Calif., to discuss what they knew and didn't know about the technology and to draw up guidelines that they hoped would let the science proceed without undue risk. Although contentious and grueling, the meeting and its resulting guidelines were generally regarded as a success, though recombinant DNA technology turned out ...
Add The Scientist as a preferred Google source to see more of our trusted coverage.
Eugene Russo is a science journalist.
View Full Profile
When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.
View this Issue
Explore strategies for improving recombinant adeno-associated virus production in transient HEK293 suspension cultures while maintaining vector quality and supporting scalable viral vector manufacturing.
Discover how tissue-resident memory T cells develop within the respiratory tract and how these findings are advancing respiratory virus immunity, vaccine research, and high-throughput immune profiling.
Bench architecture, primer design, and liquid handling set an assay's limit as throughput climbs.
Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination immunotherapy strategies may improve antitumor immune responses and patient-specific treatment approaches.
European customers can now subscribe to Sino Biological’s newsletter to receive a special gift and unlock access to EliteScience benefits.
Sino Biological’s trial program enables qualified customers to evaluate SuperNuclease Pro in their specific bioprocessing applications, facilitating faster technology assessment and informed decision-making during process development
This release expands on Sino Biological's comprehensive Tau protein product portfolio, designed to accelerate neurodegenerative disease research.
Resipher measures cellular respiration (OCR) continuously in standard 96-well plates inside your incubator, for days to weeks. No media swaps, dyes, or transfers. A live-cell functional readout for drug safety, metabolism, and mitochondrial health.
